• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD MAXZERO EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD MAXZERO EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number MZ9313
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/21/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd maxzero extension set was occluded.The following information was received by the initial reporter with the following verbatim it was reported by the customer that all 3 lumens of bd maxzero tri-fuse extension (ref mz9313), one lumen completely occluded and will not flush.Attempted multiple new sets, all had one lumen occluded and unable to flush.
 
Additional Manufacturer Narrative
2 samples were received and tested by our quality team with the customer's complaint of occlusion.The sets were tested by injecting saline solution via 20ml syringe and the customer's complaint of occlusion was immediately verified.3 max zero ends of one trifuse set and 2 of the other were occluded when an attempt to inject saline was made.The female luer ends were inspected under high power digital microscope and the female luer ends were found to have an excess of solvent applied by operator during assembly of set.This is the root cause.A quality notification has been initiated and the personnel in charge of solvent application have been further trained to eliminate further occurrences of this issue.The production history was analyzed and there were no issues found during quality inspections that would lead to this issue.
 
Event or Problem Description
Samples.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAXZERO EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key23369689
Report Number9616066-2025-03239
Device Sequence Number9931553
Product Code FPA
UDI-Device Identifier10885403471292
UDI-Public(01)10885403471292(17)271206(10)24129130
Combination Product (Y/N)N
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
K140831
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue NumberMZ9313
Device Lot Number24129130
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/30/2025
Supplement Date Received by Manufacturer01/20/2026
Initial Report FDA Received Date10/23/2025
Supplement Report FDA Received Date01/20/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/06/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-